Procyon Advisors’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Hold
1,086
0.01% 445
2026
Q1
$296K Hold
1,086
0.01% 466
2025
Q4
$313K Buy
1,086
+300
+38% +$83.8K 0.02% 427
2025
Q3
$204K Sell
786
-536
-41% -$134K 0.01% 487
2025
Q2
$328K Buy
1,322
+346
+35% +$85.5K 0.03% 356
2025
Q1
$258K Buy
976
+10
+1% +$2.66K 0.02% 511
2024
Q4
$245K Hold
966
0.02% 484
2024
Q3
$273K Hold
966
0.02% 461
2024
Q2
$257K Buy
966
+115
+14% +$30.1K 0.02% 452
2024
Q1
$230K Sell
851
-13
-2% -$3.42K 0.02% 466
2023
Q4
$217K Buy
+864
New +$205K 0.02% 476
2022
Q3
Sell
-938
Closed -$221K 335
2022
Q2
$221K Sell
938
-50
-5% -$12.1K 0.05% 293
2022
Q1
$251K Buy
988
+25
+3% +$6.18K 0.05% 282
2021
Q4
$257K Buy
+963
New +$246K 0.05% 279
2020
Q3
Sell
-129
Closed -$25K 1018
2020
Q2
$25K Hold
129
0.01% 504
2020
Q1
$21K Buy
129
+104
+416% +$19K 0.01% 479
2019
Q4
$5K Buy
+25
New +$4.48K ﹤0.01% 810

Other funds holding VHT

Procyon Advisors's VHT Position: Q2 2026 in Review

Procyon Advisors held its Vanguard Health Care ETF (VHT) position steady in Q2 2026 at 1,086 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #445.

Procyon Advisors first reported a position in VHT in Q4 2019 and has held it in 17 quarters since. The position peaked at $328K in Q2 2025. 245 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Procyon Advisors held 1,086 shares of Vanguard Health Care ETF worth $325K as of Q2 2026.
  • Procyon Advisors left its Vanguard Health Care ETF share count unchanged in Q2 2026.
  • Vanguard Health Care ETF made up 0.01% of Procyon Advisors's portfolio in Q2 2026, its #445 holding.
  • Procyon Advisors first reported a position in Vanguard Health Care ETF in Q4 2019 and has held it in 17 quarters since.
  • Procyon Advisors's Vanguard Health Care ETF position peaked at $328K in Q2 2025.
  • 245 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.